Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its price target reduced by Royal Bank of Canada from $165.00 to $161.00 ...

In a report released yesterday, Ritu Baral from TD Cowen maintained a Buy rating on Milestone Pharmaceuticals (MIST – Research Report), with a ...

The public blowup could propel President Vladimir V. Putin of Russia to escalate the fight in Ukraine instead of agreeing to peace. By Anton TroianovskiNataliya Vasilyeva and Paul Sonne After ...

How Canada plans to use Russian cash to help fund Ukraine’s war effort How Canada plans to use Russian cash to help fund Ukraine’s war effort A new idea has emerged in G7 capitals in recent ...

Sign up now for the latest news from Australia and around the world direct to your inbox.

Drench in the knowledge with exclusive insights, ePaper & smart market tools with ETPrime.